Literature DB >> 2866621

Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice.

H Fujino-Kurihara, H Fujita, A Hakura, K Nonaka, S Tarui.   

Abstract

The pancreatic islets of female non-obese diabetic (NOD) mice (a model of insulin-dependent diabetes mellitus), have been examined by both light and electron microscopy. At about the age of 2 weeks, mononuclear cells began to infiltrate in or near the islets and some of these cells were in contact with the islet cells. Following this degeneration of islet B-cells took place, the process occurring in two ways. In many cells numerous secretory granules with extremely dense cores occupied the cytoplasm. Other cells, however, were filled with low-density secretory granules and the nuclei of these cells became pycnotic. After degeneration of B-cells, the islets were effaced by numerous mononuclear cells. With the onset of the diabetic state these mononuclear cells gradually disappeared, and thereafter small islets remained. By electron microscopy, retrovirus-like particles were observed in cisternae of the rough endoplasmic reticulum in islet B-cells at all stages. With an anti-retrovirus serum (goat anti-KiMSV-NIHxeno serum), positive immunofluorescence was observed in some pancreatic islet cells of NOD mice aged 1 day and 4, 6, 8, 9, 10 and 14 weeks. It is suggested that these virus particles may be intimately related to the inflammatory reaction occurring in the islets and to the development of diabetes mellitus.

Entities:  

Mesh:

Year:  1985        PMID: 2866621     DOI: 10.1007/bf02912089

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  12 in total

1.  Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice.

Authors:  H R Gaskins; M Prochazka; K Hamaguchi; D V Serreze; E H Leiter
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Retrovirus gag protein p30 in the islets of non-obese diabetic mice: relevance for pathogenesis of diabetes mellitus.

Authors:  C Nakagawa; T Hanafusa; J Miyagawa; M Yutsudo; H Nakajima; K Yamamoto; K Tomita; N Kono; A Hakura; S Tarui
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Cell features in pancreas of prediabetic and diabetic rabbits after Wirsung duct ligation. Histochemical and histoenzymatic studies.

Authors:  J Catala; P Hadjiisky; R Bonnafous; F Fichaux
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

Review 4.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

6.  Beta cell MHC class I is a late requirement for diabetes.

Authors:  Emma E Hamilton-Williams; Stephanie E Palmer; Brett Charlton; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

7.  Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse.

Authors:  A Signore; E Procaccini; A M Toscano; E Ferretti; A J Williams; P E Beales; P Cugini; P Pozzilli
Journal:  Histochemistry       Date:  1994-04

8.  Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.

Authors:  S Reddy; N J Bibby; R B Elliott
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

Review 9.  Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Authors:  E F Lampeter; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

10.  Accelerated diabetes in non-obese diabetic (NOD) mice differing in incidence of spontaneous disease.

Authors:  A G Baxter; T E Mandel
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.